These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31860701)

  • 21. Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
    Sonalkar S; Koelper N; Creinin MD; Atrio JM; Sammel MD; McAllister A; Schreiber CA
    Am J Obstet Gynecol; 2020 Oct; 223(4):551.e1-551.e7. PubMed ID: 32305259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death.
    Väyrynen W; Heikinheimo O; Nuutila M
    Acta Obstet Gynecol Scand; 2007; 86(6):701-5. PubMed ID: 17520402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second trimester medical abortion in a primigravida with lupus nephritis and rapidly progressive renal failure: challenges and outcome.
    Bagga R; Sharma B; Choudhary N; Singla R; Saha PK; Bharati J; Rajkumar Kopp C; Jain S
    Eur J Contracept Reprod Health Care; 2021 Apr; 26(2):171-173. PubMed ID: 33615941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extending outpatient medical abortion services through 70 days of gestational age.
    Winikoff B; Dzuba IG; Chong E; Goldberg AB; Lichtenberg ES; Ball C; Dean G; Sacks D; Crowden WA; Swica Y
    Obstet Gynecol; 2012 Nov; 120(5):1070-6. PubMed ID: 23090524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea.
    Tran NT; Jang MC; Choe YS; Ko WS; Pyo HS; Kim OS
    Int J Gynaecol Obstet; 2010 Jun; 109(3):209-12. PubMed ID: 20206354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
    Heikinheimo O; Leminen R; Suhonen S
    Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial.
    Shaw KA; Shaw JG; Hugin M; Velasquez G; Hopkins FW; Blumenthal PD
    Contraception; 2015 Apr; 91(4):313-9. PubMed ID: 25499589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consistency of medical abortion efficacy from 5 through 14 weeks' gestation.
    Garbin O; Vayssiere C; Bettahar-Lebugle K; Nisand I
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):36-40. PubMed ID: 16325992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is medical abortion acceptable to all American women: the impact of sociodemographic characteristics on the acceptability of mifepristone-misoprostol abortion.
    Clark S; Ellertson C; Winikoff B
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):177-82. PubMed ID: 10846333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation.
    Tang OS; Chan CC; Ng EH; Lee SW; Ho PC
    Hum Reprod; 2003 Nov; 18(11):2315-8. PubMed ID: 14585880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early termination of pregnancy with pharmacological means].
    Honkanen H; von Hertzen H
    Duodecim; 2000; 116(12):1277-82; quiz 1283, 1308. PubMed ID: 11988962
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of mifepristone for treatment of ectopic pregnancy.
    Grossman N
    Am Fam Physician; 2006 May; 73(10):1703; author reply 1703-4. PubMed ID: 16734048
    [No Abstract]   [Full Text] [Related]  

  • 36. Options for early therapeutic abortion: a comparative review.
    Bygdeman M; Danielsson KG
    Drugs; 2002; 62(17):2459-70. PubMed ID: 12421103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
    Schreiber CA; Creinin MD; Atrio J; Sonalkar S; Ratcliffe SJ; Barnhart KT
    N Engl J Med; 2018 Jun; 378(23):2161-2170. PubMed ID: 29874535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research on regimens for early medical abortion.
    von Hertzen H
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):133-6, 150. PubMed ID: 10846322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical management of early pregnancy failure (EPF): a retrospective analysis of a combined protocol of mifepristone and misoprostol used in clinical practice.
    Colleselli V; Schreiber CA; D'Costa E; Mangesius S; Wildt L; Seeber BE
    Arch Gynecol Obstet; 2014 Jun; 289(6):1341-5. PubMed ID: 24305748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternatives to mifepristone regimens for medical abortion.
    Pymar HC; Creinin MD
    Am J Obstet Gynecol; 2000 Aug; 183(2 Suppl):S54-64. PubMed ID: 10944370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.